About Hereditary leiomyomatosis and renal cell cancer
Hereditary leiomyomatosis and renal cell cancer is a rare disease catalogued by Orphanet (ORPHA:523). It is associated with the FH gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Hereditary leiomyomatosis and renal cell cancer trials.
Search ClinicalTrials.gov for "Hereditary leiomyomatosis and renal cell cancer" or filter by Orphanet code ORPHA:523 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Hereditary leiomyomatosis and renal cell cancer trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Hereditary leiomyomatosis and renal cell cancer. Updated daily.